Randomised trial results suggest tenecteplase’s late-window benefits do not extend to bridging thrombolysis – NeuroNews International February 17, 2026 by live-feeds Randomised trial results suggest tenecteplase’s late-window benefits do not extend to bridging thrombolysis NeuroNews International Intravenous Tenecteplase Improves Functional Outcomes in Extended-Window Non-LVO Stroke HMP Global Learning Network Source link Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Related Related posts: Bei etwa zehn Prozent der Diagnosen liegen Ärzte falsch US reports first measles death since 2015 | Health News Just a moment… ‘It is not possible for people to pay for blood donation’ –